Nurix Therapeutics is trading at $24.64, down 4.03%, as broader equity sentiment weakens. - On September 23, 2026, the Nasdaq Composite is down 0.78% and the S&P 500 is down 0.44%, adding pressure to risk-sensitive stocks. - No clear company-specific announcement, earnings release, regulatory decision, or analyst action was identified. - Shares are also trading on light volume ahead of the upcoming quarterly report.